Limits on Medicare's ability to control rising spending on cancer drugs

N Engl J Med. 2009 Feb 5;360(6):626-33. doi: 10.1056/NEJMhpr0807774. Epub 2009 Jan 27.
No abstract available

MeSH terms

  • Antineoplastic Agents / economics*
  • Cost Control
  • Drug Costs / legislation & jurisprudence
  • Drug Costs / trends*
  • Health Expenditures / trends
  • Health Policy
  • Medicare / legislation & jurisprudence*
  • Reimbursement Mechanisms*
  • State Government
  • United States

Substances

  • Antineoplastic Agents